Skip to main navigation Skip to search Skip to main content

Comparison of erlotinib and pemetrexed as second-/ third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

  • Yayi He
  • , Wenwen Sun
  • , Yan Wang
  • , Shengxiang Ren
  • , Xuefei Li
  • , Jiayu Li
  • , Christopher J. Rivard
  • , Caicun Zhou
  • , Fred R. Hirsch

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of erlotinib and pemetrexed as second-/ third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science